KRAS and small cell lung carcinoma: In the case of T790M loss, several genetic alterations have been observed, including those related to transformation to small cell lung cancer, MET amplification, ERBB2 amplification/mutation, PIK3CA mutation, KRAS mutations, and oncogenic gene fusion involving RET, FGFR3, and BRAF.